What Researchers Did
Researchers presented two case reports of pediatric patients with Crohn's disease exacerbations who received hyperbaric oxygen therapy after failing prolonged medical treatment.
What They Found
In two pediatric patients with refractory Crohn's disease, both showed resolution of inflammatory lesions and improved conditions after hyperbaric oxygen therapy. This improvement allowed both patients to reduce their drug therapy, despite no prior improvement with prolonged medical treatment.
What This Means for Canadian Patients
For Canadian patients with Crohn's disease experiencing refractory exacerbations, hyperbaric oxygen therapy might offer a safe adjunctive treatment option. This therapy could potentially help reduce inflammation and improve symptoms when standard medical treatments are insufficient.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A significant limitation is the very small sample size of only two pediatric case reports, which limits generalizability and understanding of mechanisms.